![Kristina Meyer](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Kristina Meyer
Keine laufenden Positionen mehr
Vermögen: 119 716 $ am 30.06.2026
Profil
Kristina Meyer formerly worked at Sertant, Inc., as Director-Business Developments from 2002 to 2004, Thieme Medical Publishers, Inc., as Director-Business Development, Oxford BioTherapeutics Ltd., as Vice President-Business Development from 2013 to 2015, Evotec (UK) Ltd., as Vice President-Business Development from 2005 to 2013, and Inventiva SA, as EVP-Business Development & Alliance Management from 2024 to 2025.
Dr. Meyer received her doctorate degree from Johann Wolfgang Goethe-Universität Frankfurt am Main and graduate degree from Yale University.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
INVENTIVA SA 0,01 % | 01.03.2025 | 32.519 ( 0,01 % ) | 119 716 $ | 30.06.2026 |
Ehemalige bekannte Positionen von Kristina Meyer
| Unternehmen | Position | Ende |
|---|---|---|
| INVENTIVA | Corporate Officer/Principal | 01.07.2025 |
Oxford BioTherapeutics Ltd.
 Oxford BioTherapeutics Ltd. Pharmaceuticals: MajorHealth Technology Develops antibody-based medicines for oncology | Corporate Officer/Principal | 01.01.2015 |
Evotec (UK) Ltd.
 Evotec (UK) Ltd. Miscellaneous Commercial ServicesCommercial Services Provides research and development on natural sciences and engineering | Corporate Officer/Principal | 01.08.2013 |
Sertant, Inc.
 Sertant, Inc. Financial ConglomeratesFinance Operates as development stage company | Corporate Officer/Principal | 01.11.2004 |
Thieme Medical Publishers, Inc.
 Thieme Medical Publishers, Inc. Specialty StoresRetail Trade Engages in retails sales of medical and science books through online | Corporate Officer/Principal | - |
Ausbildung von Kristina Meyer
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
31
Beziehungen ersten Grades
7
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 7 |
|---|---|
Oxford BioTherapeutics Ltd.
Oxford BioTherapeutics Ltd. Pharmaceuticals: MajorHealth Technology Develops antibody-based medicines for oncology | Health Technology |
Sertant, Inc.
Sertant, Inc. Financial ConglomeratesFinance Operates as development stage company | Finance |
Yale University
 Yale University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Johann Wolfgang Goethe-Universität Frankfurt am Main
 Johann Wolfgang Goethe-Universität Frankfurt am Main Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Thieme Medical Publishers, Inc.
Thieme Medical Publishers, Inc. Specialty StoresRetail Trade Engages in retails sales of medical and science books through online | Retail Trade |
Evotec (UK) Ltd.
Evotec (UK) Ltd. Miscellaneous Commercial ServicesCommercial Services Provides research and development on natural sciences and engineering | Commercial Services |
Inventiva SA
 Inventiva SA BiotechnologyHealth Technology Operates as a clinical-stage biopharmaceutical company that develops oral small molecule therapies for the treatment of MASH and other diseases | Health Technology |
